INDIANAPOLIS, July 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2024 financial results on Aug. 8, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at . A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer to: | Jordan Bishop; jordan.bishop@lilly.com; 317-374-1878 (Media) |
| Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors) |
View original content to download multimedia:
SOURCE Eli Lilly and Company
Eli Lilly and Company (紐交所:LLY)將於2024年8月8日公佈2024年第二季度業績。屆時,公司將召開投資者電話會議並向媒體披露更多財務信息。
電話會議將於東部時間上午10點開始。投資者、媒體和公衆都可以通過Eli Lilly and Company官網上發佈的鏈接實時訪問電話會議的網絡直播。電話會議結束後,公司還將在官網上提供回放服務。
關於Lilly
Lilly是一家利用生物技術,推動科技創新實現人類疾病治癒的藥品公司,致力於讓世界各地的人們享用更好的生活。我們擁有近150年的生物技術研究和發現歷史,現已向全球5100萬人提供治療藥品。我們的科學家藉助生物技術、化學與基因藥物的力量,積極推進各項創新。我們正在應對一些全球性的重大健康挑戰,重新定義糖尿病護理,治療和控制肥胖症最具破壞性的長期後果,致力於抗擊阿爾茨海默病,爲一些難以治療的免疫系統疾病提供解決方案,並將最難治療的癌症轉化爲可控制的疾病。每向更健康的世界邁進一步,我們的動力都源於一個信念:爲數百萬人提供更好的生活。我們還通過反映世界多元化的創新性臨床試驗以及努力使我們的藥品易於獲取和負擔得起來實現了這一信念。要了解更多信息,請訪問Lilly.com和Lilly.com/news或關注我們的Facebook、Instagram和LinkedIn。F-LLY
喬丹·畢曉普; jordan.bishop@lilly.com | 喬丹·畢夏普;jordan.bishop@lilly.com;317-374-1878(媒體) |
| 喬·弗萊徹;jfletcher@lilly.com;317-296-2884(投資者) |
查看下載多媒體原始內容:
資訊 Eli Lilly and Company